Selected Publications

  • Lens MB, Dawes M, Goodacre T, Newton-Bishop JA. Elective lymph node dissection in patients with melanoma. Systematic review and meta-analysis of randomised controlled trials. Arch Surg 2002;137:458-61.
  • Lens MB, Dawes M, Goodacre T, Newton-Bishop JA. Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomised controlled trials comparing narrow vs.wide excision. Arch Surg 2002;137(10):1101-5.
  • Lens MB, Dawes M, Newton-Bishop JA, Goodacre T. Tumour thickness as a predictor of occult metastasis in melanoma patients stage I and II undergoing sentinel lymph node biopsy. Br J Surg 2002;89:1223-1227.
  • Lens MB, Dawes M. Interferon alfa therapy for malignant melanoma: a systematic review of randomised controlled trials. J Clin Oncol 2002;20:1818-25.
  • Lens MB, Dawes M, Goodacre T, Newton-Bishop JA. Management of regional lymph nodes in patients with malignant melanoma: questionnaire survey of the UK current practice. Br J Plast Surg 2002;55:372-375.
  • Lens MB, Dawes M. Isolated limb perfusion in patients with limb melanomas. Lancet Oncol 4(6):359-64.
  • Lens MB, Reiman T, Husain AF. Use of tamoxifen in the treatment of malignant melanoma: systematic review and meta-analysis of randomized controlled trials. Cancer 98(7):1355-1361.
  • Lens MB. Systemic chemotherapy in the treatment of malignant melanoma. Expert Opin Pharmacotherap 2003; 4(12):2205-11.
  • Lens MB, Eisen T. The role of biological response modifiers in malignant melanoma. Expert Opin Biol Ther 2003; 3(8):1225-31.
  • Lens MB, Newton-Bishop JA, Dawes M. Excision margins for cutaneous melanoma: an update of the current evidence from meta-analysis. Cancer 2003;100(2):433.
  • Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004;150:179-185.
  • Lens MB, Rosdahl I, Ahlbom A, Farahmand BY, Synnerstad I, Boeryd B, Newton-Bishop J. Effect of pregnancy on survival in women with cutaneous malignant melanoma. J Clin Oncol 2004;22(21):4369-4375.
  • Lens MB, Newton-Bishop JA. An association between cutaneous melanoma and non-Hodgkin’s lymphoma: pooled analysis of published data with a review. Ann Oncol 2005;16(3):460-5.
  • Lens MB, Newton-Bishop JA, Boon AP. Desmoplastic malignant melanoma: a systematic review. Br J Dermatol 2005;152(4):673-8.
  • Lens M. Cutaneous melanoma: interferon alpha adjuvant therapy for patients at high risk for recurrent disease. Dermatol Ther 2006;19:9-18.
  • Bataille V, Kato BS, Falchi M, Gardner J, Kimura M, Lens M, et al. Nevus size and number are associated with telomere length and represent potential markers of a decreased senescence in vivo. Cancer Epidemiol Biomarkers Prev 2007;16(7):1499-502.
  • Bishop JN, Bataille V, Gavin A, Lens M, Marsden J, Mathews T, Wheelhouse C. The prevention, diagnosis, referral and management of melanoma of the skin: concise guidelines. Clin Med 2007;7(3):283-90.
  • Lens M, Bataille V, Nathan P. Excision margins for primary cutaneous melanoma: updated pooled analysis of randomized controlled trials. Arch Surg 2007;142(9):885-91.